gms | German Medical Science

90. Versammlung des Vereins Rhein-Mainischer Augenärzte

Verein Rhein-Mainischer Augenärzte

04.11.2017, Marburg

The effect of antiamoebic agents on the viability of human epithelial cells, keratocytes and endothelial cells, in vitro

Meeting Abstract

  • L. Shi - Universitäts-Augenklinik Homburg/Saar
  • T. Stachon - Universitäts-Augenklinik Homburg/Saar
  • B. Seitz - Universitäts-Augenklinik Homburg/Saar
  • A. Langenbucher - Institut für Experimentelle Ophthalmologie, Universitäts-Augenklinik Homburg/Saar
  • N. Szentmáry - Universitäts-Augenklinik Homburg/Saar; Klinik für Augenheilkunde, Semmelweis Universität, Budapest, Ungarn

Verein Rhein-Mainischer Augenärzte. 90. Versammlung des Vereins Rhein-Mainischer Augenärzte. Marburg, 04.-04.11.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. DocP05

doi: 10.3205/17rma42, urn:nbn:de:0183-17rma421

Published: November 3, 2017

© 2017 Shi et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Background and purpose: Persisting epithelial defects are major complications of effective acanthamoeba keratitis therapy. The purpose of this study was to analyze the effects of different concentrations of diamidines (hexamidine diisethionat (HD), propamidin isethionate (PD), dibromopropamidine diisethionat (DD)) and biguanides (polyhexamethylen biguanid (PHMB), chlorhexidine (CH)) on human corneal epithelial cells, keratocytes and endothelial cells, in vitro.

Methods: For epithelial (HCEC) and endothelial cells (HCEC-12) a human cell line and for keratocytes primary cultures were used (n=6 each). We used 3.9x10-4-0.1% HD, PD or DD, 3.9x10-4-0.0125% PD and 7.8x10-5-0.02% PHMB or CH concentrations for 24 hours for our experiments. Cell cultures without diamidine or biguanide were used as controls. Viability was analyzed using Cell Proliferation Kit XTT.

Results: Epithelial cell viability decreased significantly from 7.8x10-4% DD, 1.6x10-3% HD and 3.1x10-3% PD and from 3.1x10-4% PHMB and CH concentrations (P≤0.038), keratocyte viability decreased significantly from 7.8x10-4% DD and HD, 3.1x10-3% PD, 3.1x10-4% PHMB and 6.3x10-4% CH concentrations (P≤0.038), endothelial cell viability decreased significantly from 1.6x10-3% HD, 3.1x10-3% DD, 6.3x10-3% PD, 6.3x10-4% PHMB or CH concentrations (P≤0.038), compared to controls. At 6.3x10-3% concentration, epithelial cell viability was significantly less using DD or HD than using the same PD concentration (P=0.026; P=0.011). It was significantly worse using 6.3 x10-4% or 1.3 x10-3% PHMB than using the same CH concentration (P=0.011; P=0.007). Keratocyte / endothelial cell viability was significantly worse using 3.1x10-3% HD, than using the same concentration of DD or PD (P=0.004/P=0.017; P=0.001/P=0.0006). Keratocyte viability was significantly less using 3.1x10-4% or 6.3x10-4% CH than using the same concentration of PHMB (P=0.017; P=0.0006).

Conclusion: PD decreases human cell viability less than DD and HD, whereas CH decreases viability less than PHMB. Our result suggest, that propamidin isethionate as diamidine and chlorhexidin as biguanide should be used in order to reduce cytotoxicity of antiacanthemoeba treatment on human epithelial cells, keratocytes and endothelial cells.